Completed Clinical Trials and Follow-Up Information
- MesoblastMesenchymal Stem Cells in lumbar fusion, study completed
- MesoblastMesenchymal Stem Cells in cervical fusion, study completed
- MesoblastMesenchymal Stem Cell Injectable Disc Repair study, Phase II, for lumbar DDD, enrollment closed, in active follow-up
- Relievant SMART, for lumbar modic changes, enrollment closed, in active follow-up
- ISTO NuQu Injectable Chondrocytes, for lumbar DDD, enrollment closed, in active follow-up
- BionessStimrouter, for peripheral neuropathy, enrollment closed, in active follow-up
The following include clinical trials with treatments that have received FDA approval and are now available to the general public:
- CoflexInterspinous Spacer by Paradigm Spine, for lumbar spinal stenosis, study completed, FDA-approved
- Prodisc-C cervical artificial disc replacement, by DePuy/Synthes Spine, approved for 1-level, study completed, FDA-approved
- Prodisc-L lumbar artificial disc replacement, by DePuy/Synthes Spine, approved for 1-level, study completed, FDA-approved
- Mobi-C Cervical Disc by LDR Spine, for cervical DDD, approved for 1 and 2-level, study completed, FDA-approved
For more information about any of the above research projects or clinical trials, reach out to us today at (310) 828-7757.
Lacey Feldman, Research Coordinator
Phone: (310) 828.7757